drugset

drugset / Trial / NCT05691881

68Ga-labeled NY105 PET Imaging in Patients

NCT05691881 ↗

Phase 0 Unknown 10 enrolled Affiliated Hospital of Jiangnan University

NaSingle-groupOpen-labelDiagnostic

Summary

This is a single arm study to evaluate the safety and biodistribution of 68Ga-labeled NY105 PET Imaging in patients

Timeline

Start: 2022-09-28
Primary completion: 2023-03
Completion: 2023-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NY105	Unknown	—	Intravenous

Indications